Curran Biotech's Capture Coating™ Grows Network to Stop the Spread of COVID-19 Variants, Including Omicron

(Left to right) Professor Shay Curran, Dr. Ken Russell with Kathy Ireland

HOUSTON, Dec. 20, 2021 /PRNewswire/ -- Leading nanotech company, Curran Biotech, recognized the viral transmission of COVID-19, including Delta and the new Omicron variants, was in the air and not on surfaces so they developed Capture Coating™ for ordinary air filters. The revolutionary new nanocoating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pretreated air filters.

Capture Coating™ is protecting work environments and public gathering spaces including those at Comcast, Camden Properties, correctional facilities, hospitals, school districts, and universities. With the success of the introduction of the coated air filters, Curran Biotech announces distribution throughout North America and Western Europe.

Also available in 10 oz or 330 mL spray bottles

"We are addressing the need for getting Capture Coating™ to as many people as we can, as quickly as possible," says Professor Shay Curran, Curran Biotech founder. "Our coating establishes a permanent, water-repellent, antiviral barrier on the air filter in your home or office. In fact, Capture Coating™ enables less expensive filters rated as MERV 8 to perform better than MERV 13 without a dramatic change in filter expense or installation of new capital equipment."

Capture Coating™ has been independently tested and has been found to transform everyday air filters into a viral fighting front-line tool in the battle against COVID-19, stopping the virus, variants, and other aqueous airborne contagions at the air filter within HVAC heating and cooling systems.

Read more…